Documents & Downloads

Yimitasvir

NS5A Inhibitor

Yimitasvir is an orally active inhibitor targeting the hepatitis C virus (HCV) nonstructural protein 5A (NS5A). It demonstrates significant antiviral activity and is primarily utilized in research related to chronic HCV infection. Its inhibitory action on NS5A makes it a valuable tool for studying HCV replication and potential therapeutic strategies.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	1959593-23-7
Applications	NS5A Inhibitor
Formula	C₄₉H₅₈N₈O₆
Molecular Weight	855.03
Synonyms	Emitasvir; DAG-181
SMILES	COC(N[C@@H](C(C)C)C(N1[C@@H](CCC1)C2=NC3=CC=C(C4=C5C([C@H]6C[C@@H]5CC6)=C(C7=CC=C(C8=CN=C([C@H]9N(CCC9)C([C@H](C(C)C)NC(OC)=O)=O)N8)C=C7)C=C4)C=C3N2)=O)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.